Ruffer LLP Bristol Myers Squibb CO Transaction History

Ruffer LLP

$2.91 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $4.76 Million - $5.4 Million	-72,451 Reduced 94.15%	4,504 $312,000
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $18 Million - $21.3 Million	-262,276 Reduced 77.31%	76,955 $5.54 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $156,984 - $92.8 Million	-1,207,574 Reduced 78.07%	339,231 $23.8 Million
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $128 Million - $141 Million	-1,761,973 Reduced 53.25%	1,546,805 $119 Million
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $100 Million - $120 Million	-1,628,767 Reduced 32.99%	3,308,778 $242 Million
Q4 2021 Feb 04, 2022	BUY	$53.63 - $62.52 $53 Million - $61.8 Million	988,450 Added 25.03%	4,937,545 $306 Million
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $17.8 Million - $20.8 Million	-300,178 Reduced 7.06%	3,949,095 $234 Million
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $3.25 Million - $3.53 Million	52,417 Added 1.25%	4,249,273 $284 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $138 Million - $155 Million	2,327,044 Added 124.45%	4,196,856 $265 Million
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $93.4 Million - $106 Million	1,617,638 Added 641.48%	1,869,812 $116 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $171,887 - $190,474	-2,993 Reduced 1.17%	252,174 $15.2 Million
Q2 2020 Aug 04, 2020	SELL	$54.82 - $64.09 $26.1 Million - $30.5 Million	-475,735 Reduced 65.09%	255,167 $15.8 Million
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $210 Million - $305 Million	-4,522,472 Reduced 86.09%	730,902 $40.7 Million
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $253 Million - $330 Million	5,135,274 Added 4348.24%	5,253,374 $337 Million
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $144,134 - $170,892	-3,370 Reduced 2.77%	118,100 $5.99 Million
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $5.42 Million - $5.99 Million	121,470 New	121,470 $5.51 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruffer LLP, based on Form 13F filings with the SEC.

News

Stay updated on Ruffer LLP with notifications on news.

Account